Applied Therapeutics, Inc. Accrued Professional Fees, Current
Applied Therapeutics, Inc. had Accrued Professional Fees, Current of $989.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2025-11-13
- 2025-09-30: Accrued Professional Fees, Current $989.00K.
- 2025-06-30: Accrued Professional Fees, Current $2.66M.
- 2025-03-31: Accrued Professional Fees, Current $4.11M.
- 2024-12-31: Accrued Professional Fees, Current $2.94M; Accrued Professional Fees, Current as first filed $2.91M.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2025-09-30 | $989.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.66M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $4.11M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.94M 10-Q · filed 2025-11-13 | $2.91M 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.17M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.11M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.24M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.31M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.03M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.12M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $387.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $837.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $681.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $533.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $419.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $740.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $608.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $359.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $511.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $996.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $763.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $898.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $345.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $248.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $293.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.10M 10-Q · filed 2019-06-21 | |
| 2018-12-31 | $312.00K 10-K · filed 2020-03-13 |